Annexon to Present at the J.P. Morgan 39th Annual Healthcare Conference

Rhea-AI Summary

Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical firm focused on autoimmune and neurodegenerative disorders, announced a corporate update presentation at the 39th Annual J.P. Morgan Healthcare Conference on January 12, 2021, at 4:30 PM ET. The event will be accessible via a live webcast on their Investors page, with a replay available for 30 days post-event. Annexon is developing innovative therapies based on its technology targeting classical complement-mediated disorders, employing a biomarker-driven strategy to enhance patient identification and treatment response evaluation.

SOUTH SAN FRANCISCO, Calif., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Annexon, Inc. (“Annexon”) (Nasdaq: ANNX), a clinical stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated autoimmune and neurodegenerative disorders of the body, brain and eye, today announced that a corporate update will be presented at the 39^th Annual J.P. Morgan Healthcare Conference on January 12, 2021 at 4:30pm ET.

A live webcast of the event can be accessed under the ‘Events & Presentations’ section on the Investors page at www.annexonbio.com. A replay of the webcast will be archived on the Annexon website for 30 days following the presentation.

About Annexon, Inc.
Annexon is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain and eye. The company’s pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q, the initiating molecule of the classical complement pathway. Annexon is deploying a disciplined, biomarker-driven development strategy designed to identify patients, and to measure target engagement and response to treatment. For more information, visit www.annexonbio.com.

FAQ

What is the date and time of Annexon's presentation at the J.P. Morgan Healthcare Conference?

Annexon's presentation is scheduled for January 12, 2021, at 4:30 PM ET.

How can I access the live webcast of Annexon's corporate update?

The live webcast can be accessed on Annexon's Investors page under the ‘Events & Presentations’ section.

Will there be a replay of Annexon's presentation available?

Yes, a replay of the presentation will be available on Annexon's website for 30 days following the event.

What focus areas does Annexon specialize in?

Annexon specializes in novel therapies for classical complement-mediated autoimmune and neurodegenerative disorders.

What is the stock ticker for Annexon?

Annexon's stock ticker is ANNX.